ClassID:

21647

A61K2300/00 - page 31 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#9001
20110123513
2011-05-26

Alkaline phosphatase to reduce weight gain or induce weight loss

#9002
20110123507
2011-05-26

Ultra low dose nutraceutical compositions for enhancing sleep quality and treating sleep disorders

#9003
20110123497
2011-05-26

GRAFT COMPOSITION FOR NEURAL TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF

#9004
20110123494
2011-05-26

TREATMENT WITH ANTI-VEGF ANTIBODIES

#9005
20110123492
2011-05-26

Method for inducing immunity with a peptide fragment from human CAPRIN-1

#9006
20110123487
2011-05-26

Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides

#9007
20110123484
2011-05-26

METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS

#9008
20110123483
2011-05-26

HMGB1 FOR CANCER TREATMENT

#9009
20110123482
2011-05-26

Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide

#9010
20110123481
2011-05-26

ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS

#9011
20110123437
2011-05-26

COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR

#9012
20110123434
2011-05-26

Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer

#9013
20110121033
2011-05-26

Skincare Treatment

#9014
20110118825
2011-05-19

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#9015
20110118350
2011-05-19

COMPOSITION FOR PREVENTING CARDIOVASCULAR EVENT IN HIGH-RISK PATIENT

#9016
20110118349
2011-05-19

Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions

#9017
20110118345
2011-05-19

Composition and method for treating diabetes and metabolic disorders

#9018
20110118342
2011-05-19

COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY

#9019
20110118327
2011-05-19

In vivo assessment of toxicity and pharmacokinetics of methylglyoxal

#9020
20110118299
2011-05-19

Treatment of MCI and Alzheimer's disease

#9021
20110118297
2011-05-19

Tivozanib and temsirolimus in combination

#9022
20110118292
2011-05-19

METHOD OF TREATING ATHEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS

#9023
20110118289
2011-05-19

6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands

#9024
20110118288
2011-05-19

Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof

#9025
20110118243
2011-05-19

ANTI-INFLAMMATORY DRUG DELIVERY SYSTEM

#9026
20110118223
2011-05-19

Quinuclidine derivatives and medicinal compositions containing the same

#9027
20110118220
2011-05-19

Composition of bifonazole and its use

#9028
20110118219
2011-05-19

NOVEL PRODRUGS OF C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS: SYNTHESIS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY

#9029
20110118209
2011-05-19

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#9030
20110118205
2011-05-19

Anti-tumor agent comprising cytidine derivative and carboplatin

#9031
20110118188
2011-05-19

Factor VIII polypeptide having factor VIII:C activity

#9032
20110118181
2011-05-19

PCSK9 inhibitors and methods of use thereof

#9033
20110118180
2011-05-19

METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO METFORMIN

#9034
20110118179
2011-05-19

Cation complexes of insulin compound conjugates, formulations and uses thereof

#9035
20110118178
2011-05-19

METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO INSULIN GLARGINE AND METFORMIN

#9036
20110118176
2011-05-19

Controlling diseases caused by trichomonadida

#9037
20110118174
2011-05-19

TREATMENT SOLUTION AND METHOD FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION BY SELECTIVELY INDUCING DETACHMENT AND/OR DEATH OF LENS EPITHELIAL CELLS

#9038
20110117228
2011-05-19

Compositions and methods for enhancing and treating female sexual response

#9039
20110117223
2011-05-19

Antiseptics

#9040
20110117222
2011-05-19

Pharmaceutical Compositions for the Treatment of Warts

#9041
20110117218
2011-05-19

Composition and uses for influencing hair growth

#9042
20110117216
2011-05-19

Anti-tumoural effects of cannabinoid combinations

#9043
20110117213
2011-05-19

TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM

#9044
20110117212
2011-05-19

THERAPEUTIC COMBINATION COMPRISING AN AURORA KINASE INHIBITOR AND AN ANTINEOPLASTIC AGENT

#9045
20110117210
2011-05-19

Therapeutic treatment of human cancers using simple salts of zinc

#9046
20110117207
2011-05-19

USE OF EGGSHELL MEMBRANE FORMULATIONS TO ALLEVIATE JOINT PAIN

#9047
20110117193
2011-05-19

ANTIRETROVIRAL DRUG FORMULATIONS FOR TREATMENT OF CHILDREN EXPOSED TO HIV/AIDS

#9048
20110117192
2011-05-19

Carbidopa/Levodopa gastroretentive drug delivery

#9049
20110117191
2011-05-19

MIXTURE OF SUBSTANCES ON THE BASIS OF A MIXTURE OF ESSENTIAL OILS AND USE

#9050
20110117182
2011-05-19

COMBINATION OF DAPSONE WITH OTHER ANTI-ACNE AGENTS

#9051
20110117179
2011-05-19

Compositions comprising elemental metals

#9052
20110117154
2011-05-19

USE OF RIFALAZIL TO TREAT COLONIC DISORDERS

#9053
20110117107
2011-05-19

Compositions and methods for diagnosis, prognosis and management of malaria

#9054
20110117102
2011-05-19

Therapeutic uses of inhibitors of RTP801

#9055
20110117098
2011-05-19

Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer

#9056
20110117085
2011-05-19

Monoclonal antibodies for tumor treatment

#9057
20110117078
2011-05-19

Methods for the treatment of cancers

#9058
20110117077
2011-05-19

NUTRITIONAL COMPOSITION FOR INFANTS DELIVERED VIA CAESAREAN SECTION

#9059
20110117071
2011-05-19

Antimicrobial composition

#9060
20110117070
2011-05-19

COMPOSITIONS AND METHODS FOR TREATING HEADACHE

#9061
20110117065
2011-05-19

Compositions and methods for obtaining cells to treat heart tissue

#9062
20110117060
2011-05-19

CANCER TREATMENT USING VIRUSES, FLUOROPYRIMIDINES AND CAMPTOTHECINS

#9063
20110117059
2011-05-19

Composition of soluble indigestible fibre and of microalgae used in the well-being field

#9064
20110117055
2011-05-19

Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds

#9065
20110117054
2011-05-19

USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER

#9066
20110117049
2011-05-19

Methods and compositions for modulating adipocyte function

#9067
20110117048
2011-05-19

Method and composition for use in preparation of a patient for surgery

#9068
20110117036
2011-05-19

Compositions and methods for improving skin appearance

#9069
20110117030
2011-05-19

Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections

#9070
20110117011
2011-05-19

Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereof

#9071
20110117008
2011-05-19

USE OF AVICINS TO DELIVER THERAPEUTIC AND DIAGNOSTIC AGENTS

#9072
20110112655
2011-05-12

Device for regeneration of articular cartilage and other tissue

#9073
20110112468
2011-05-12

Device and method for treatment of surface infections with nitric oxide

#9074
20110112196
2011-05-12

NRF2 SCREENING ASSAYS AND RELATED METHODS AND COMPOSITIONS

#9075
20110112188
2011-05-12

Treatment of Inflammatory Conditions

#9076
20110112137
2011-05-12

HIV protease inhibitor and cytochrome p450 inhibitor combinations

#9077
20110112123
2011-05-12

Compositions for intratumoral administration

#9078
20110112117
2011-05-12

Treatment of herpes virus related diseases

#9079
20110112116
2011-05-12

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

#9080
20110112111
2011-05-12

Drug combinations comprising a DGAT inhibitor and a PPAR-agonist

#9081
20110112099
2011-05-12

THERAPEUTIC AGENT FOR CANCER RESISTANT TO PROTEASE INHIBITOR

#9082
20110112095
2011-05-12

1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof

#9083
20110112073
2011-05-12

Substituted pyrazoles as heat shock transcription factor activators

#9084
20110112057
2011-05-12

Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders

#9085
20110112052
2011-05-12

Spiro-oxindole MDM2 antagonists

#9086
20110112034
2011-05-12

Modulation of synaptogenesis

#9087
20110112030
2011-05-12

Methods of treating or preventing stent thrombosis

#9088
20110112023
2011-05-12

von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes

#9089
20110112014
2011-05-12

Supplementation of propane-1,2,3-triol and water in fasting subjects

#9090
20110112010
2011-05-12

OCTANOIC ACID FORMULATIONS AND METHODS OF TREATMENT USING THE SAME

#9091
20110111074
2011-05-12

Medicine to treat drug addiction and preparation method thereof

#9092
20110111072
2011-05-12

Methods for preventing and treating neurodegenerative diseases

#9093
20110111070
2011-05-12

USE OF PHY906 AS TREATMENT FOR INFLAMMATORY BOWEL DISEASE AND/OR IRRITABLE BOWEL SYNDROME

#9094
20110111066
2011-05-12

Method and composition for improved anabolism

#9095
20110111060
2011-05-12

COMPOSITIONS, FORMULATIONS, AND METHODS FOR PREVENTING AND/OR TREATING PHYSICAL EFFECTS OF ALCOHOL CONSUMPTION

#9096
20110111057
2011-05-12

Methods and compounds useful to induce apoptosis in cancer cells

#9097
20110111055
2011-05-12

NUTRITIONAL SUPPLEMENTS FOR RELIEF OF DRY EYE

#9098
20110111051
2011-05-12

Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent

#9099
20110111050
2011-05-12

Herbal medicinal composition and herbal medicinal extract for inducing production of peripheral blood stem cells and method for preparing the same

#9100
20110111049
2011-05-12

Ischemia/reperfusion protection compositions and methods of using

#9101
20110111047
2011-05-12

Combination preparation of a biological response modifier and an anticancer agent and uses thereof

#9102
20110111039
2011-05-12

Compositions and methods for inhibiting gastric acid secretion

#9103
20110111031
2011-05-12

Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof

#9104
20110111024
2011-05-12

Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use

#9105
20110111022
2011-05-12

PHARMACEUTICAL FORMULATION

#9106
20110111016
2011-05-12

NON-DNA BASE-CONTAINING POLYNUCLEOTIDE COMPOSITIONS AND THEIR USE FOR THE MODULATION OF IMMUNE RESPONSES

#9107
20110110988
2011-05-12

Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound

#9108
20110110956
2011-05-12

Heparin-binding epidermal growth factor-like growth factor binding proteins

#9109
20110110941
2011-05-12

Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents

#9110
20110110940
2011-05-12

Methods for Enhancing the Efficacy of Vascular Disrupting Agents

#9111
20110110939
2011-05-12

Methods and compositions for the treatment and diagnosis of systemic anthrax infection

#9112
20110110934
2011-05-12

Treatment of uveitis

#9113
20110110933
2011-05-12

Ectopic pregnancy treatment

#9114
20110110932
2011-05-12

COMBINATION TREATMENT FOR OCULAR DISEASES

#9115
20110110930
2011-05-12

Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects

#9116
20110110921
2011-05-12

Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI

#9117
20110110913
2011-05-12

Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders

#9118
20110110907
2011-05-12

Composition of soluble indigestible fibers and of eukaryotic organisms with a polysaccharide wall, used in the well-being field

#9119
20110110905
2011-05-12

Infant Colic Supplement

#9120
20110110903
2011-05-12

CELL FUSION PROMOTER AND UTILIZATION OF THE SAME

#9121
20110110898
2011-05-12

Bioactive removal of hypertrophic scars

#9122
20110110891
2011-05-12

Methods of Treating Hepatitis C Virus Infection

#9123
20110110886
2011-05-12

SMALL MOLECULE INHIBITORS OF AUTOTAXIN AND METHODS OF USE

#9124
20110110884
2011-05-12

IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#9125
20110110876
2011-05-12

Sprayable beautifying composition

#9126
20110105623
2011-05-05

USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY

#9127
20110105621
2011-05-05

METHOD OF REDUCING BRAIN CELL DAMAGE, INFLAMMATION OR DEATH

#9128
20110105620
2011-05-05

ORGANIC COMPOUNDS

#9129
20110105601
2011-05-05

COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK

#9130
20110105600
2011-05-05

SYNERGISTIC COMPOSITION OF (-)-HYDROXYCITRIC ACID WITH MONOTERPENE AND A METHOD TO ENHANCE SATIETY

#9131
20110105594
2011-05-05

Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

#9132
20110105559
2011-05-05

Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy

#9133
20110105557
2011-05-05

FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH ANTIESTROGEN AGENTS

#9134
20110105521
2011-05-05

COMBINATION OF (A) A PHOSPHOINOSITIDE 3-KINASE INHIBITOR AND (B) A MODULATOR OF RAS/RAF/MEK PATHWAY

#9135
20110105519
2011-05-05

Pharmaceutical Compositions for the Treatment of Sexual Disorders II

#9136
20110105510
2011-05-05

PROPHYLACTIC/AMELIORATING OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC STEATOHEPATITIS

#9137
20110105505
2011-05-05

Thiazolyl piperidine derivatives

#9138
20110105501
2011-05-05

Pharmaceutical combinations

#9139
20110105480
2011-05-05

PHARMACEUTICAL TRANSDERMAL COMPOSITIONS AND METHOD FOR TREATING INFLAMMATION IN CATTLE

#9140
20110105465
2011-05-05

Inhibitor of analgesic tolerance

#9141
20110105448
2011-05-05

Stable Topical Formulation Comprising Voriconazole

#9142
20110105434
2011-05-05

2-AMINO PURINE DERIVATIVES AND THEIR USE AS ANTI-HERPETIC AGENTS

#9143
20110105432
2011-05-05

Aminocarboxylic acid derivative and medicinal use thereof

#9144
20110105422
2011-05-05

USE OF G-RICH OLIGONUCLEOTIDES FOR TREATING NEOPLASTIC DISEASES

#9145
20110105421
2011-05-05

ELLAGITANNINS AS INHIBITORS OF BACTERIAL QUORUM SENSING

#9146
20110105419
2011-05-05

PHARMACOLOGICAL ADJUVANTS BASED ON COORDINATION COMPOUNDS OF D-METALS

#9147
20110105418
2011-05-05

Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof

#9148
20110105393
2011-05-05

METHODS FOR PROMOTING STEM CELL PROLIFERATION AND SURVIVAL

#9149
20110105388
2011-05-05

Controlling giardiosis

#9150
20110105386
2011-05-05

USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS

#9151
20110104727
2011-05-05

ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE

#9152
20110104313
2011-05-05

COMPOSITIONS FOR THE TREATMENT OF VAGINAL INFECTIONS WITH CHRONIC INFLAMMATION

#9153
20110104308
2011-05-05

Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide

#9154
20110104304
2011-05-05

O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders

#9155
20110104302
2011-05-05

Composition and method for treating viral conditions

#9156
20110104283
2011-05-05

Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis

#9157
20110104282
2011-05-05

New Therapy of Treatment of the Irritable Bowel Syndrome

#9158
20110104267
2011-05-05

Pharmaceutical compositions of antiretrovirals

#9159
20110104264
2011-05-05

Gastric acid secretion inhibiting composition

#9160
20110104262
2011-05-05

Topical Combinations Comprising an Antimycotic Agent and an Antiviral Agent

#9161
20110104256
2011-05-05

METHODS FOR TREATING OR PREVENTING COLORECTAL CANCER

#9162
20110104254
2011-05-05

Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells

#9163
20110104251
2011-05-05

Cosmetic composition and method for retarding hair growth

#9164
20110104243
2011-05-05

First aid formulations of turmeric powder lavender essential oil and glycerin for dressing wounds

#9165
20110104237
2011-05-05

Bone strengthening food supplement

#9166
20110104236
2011-05-05

Therapeutic compositions for treatment of ocular inflammatory disorders

#9167
20110104210
2011-05-05

Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors

#9168
20110104207
2011-05-05

Gyrase inhibitors and uses thereof

#9169
20110104185
2011-05-05

Antibody fragment-polymer conjugates and uses of same

#9170
20110104184
2011-05-05

ANTIBODIES FOR INHIBITING BLOOD COAGULATION AND METHODS OF USE THEREOF

#9171
20110104182
2011-05-05

CD40 ANTIBODY FORMULATION AND METHODS

#9172
20110104177
2011-05-05

HISTONE DEACETYLASE INHIBITORS, COMBINATION THERAPIES AND METHODS OF USE

#9173
20110104161
2011-05-05

COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER

#9174
20110104160
2011-05-05

Medicament for treatment cancer

#9175
20110104159
2011-05-05

COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY

#9176
20110104157
2011-05-05

LIVER CANCER DRUG

#9177
20110104155
2011-05-05

DRUG DELIVERY TO THE ANTERIOR AND POSTERIOR SEGMENTS OF THE EYE USING EYE DROPS

#9178
20110104153
2011-05-05

USE OF IMMUNOREGULATORY NK CELL POPULATIONS FOR PREDICTING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS

#9179
20110104144
2011-05-05

METHODS FOR TREATING CUTANEOUS LUPUS USING AMINOISOINDOLINE COMPOUNDS

#9180
20110104137
2011-05-05

ADJUNCTS AND COMPLEXES FOR IMPROVING HMG-CoA REDUCTASE INHIBITOR (STATIN) AND SELECTIVE PHOSPHODIESTERASE 5 INHIBITOR THERAPY

#9181
20110104127
2011-05-05

mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION

#9182
20110104115
2011-05-05

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#9183
20110104109
2011-05-05

TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS

#9184
20110104107
2011-05-05

COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION

#9185
20110104106
2011-05-05

COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION

#9186
20110104080
2011-05-05

Oral Compositions for Treatment of Dry Mouth

#9187
20110104065
2011-05-05

Methods of treating pre-malignant ductal cancer with autophagy inhibitors

#9188
20110104061
2011-05-05

Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation

#9189
20110104060
2011-05-05

Treatment of hypertension by renal vascular delivery of guanethidine

#9190
20110098469
2011-04-28

1-thio-D-glucitol derivatives

#9191
20110098358
2011-04-28

HUMAN BETA3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME

#9192
20110098349
2011-04-28

CATHECHINS FOR THE TREATMENT OF SYSTEMIC AA AMYLOIDOSIS

#9193
20110098347
2011-04-28

PHOSPHOROUS BINDER FOR TREATMENT OF KIDNEY DISEASE

#9194
20110098318
2011-04-28

FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER

#9195
20110098311
2011-04-28

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

#9196
20110098306
2011-04-28

Treatment for gastroparesis using sepiapterin

#9197
20110098303
2011-04-28

Method of promoting nail growth using thyromimetic compounds

#9198
20110098289
2011-04-28

METHOD FOR TREATING OBESITY

#9199
20110098284
2011-04-28

Methods and compositions for treating pain

#9200
20110098256
2011-04-28

Method for making and using a topical dermatological solution

#9201
20110098255
2011-04-28

COMBINATION OF A PARP INHIBITOR AND AN AKT KINASE ACTIVATING COMPOUND

#9202
20110098240
2011-04-28

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR

#9203
20110098232
2011-04-28

Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis

#9204
20110098229
2011-04-28

Compositions and methods for treating dermatological conditions

#9205
20110098221
2011-04-28

INHIBITORS OF Akt ACTIVITY

#9206
20110098220
2011-04-28

Methods and kits for preventing hypoglycemia

#9207
20110098219
2011-04-28

System for Curing Hepatic Cancer with Leptin

#9208
20110097437
2011-04-28

NUTRITION FOR PREVENTION OF INFECTIONS

#9209
20110097427
2011-04-28

Molecular Targets and Dietary Modulators of Exercise-Induced Muscle Damage

#9210
20110097424
2011-04-28

Herbal formulations for the management of chronic ulcers and wounds

#9211
20110097409
2011-04-28

PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE HAVING IMPROVED ADHESION PROPERTIES FOR POWDER FORMULATIONS FOR INHALATION

#9212
20110097393
2011-04-28

Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery

#9213
20110097382
2011-04-28

METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION

#9214
20110097379
2011-04-28

Renal tissue regeneration

#9215
20110097364
2011-04-28

MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE

#9216
20110097361
2011-04-28

Method of inducing tolerance to an allergen

#9217
20110097356
2011-04-28

Anti-inflammatory and antioxidant cosmetic composition containing green tea polysaccharide and tricholoma matsutake extract

#9218
20110097347
2011-04-28

Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)

#9219
20110097337
2011-04-28

Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells

#9220
20110097321
2011-04-28

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCER

#9221
20110097312
2011-04-28

ANTI-CANCER VACCINES

#9222
20110097307
2011-04-28

Compositions and methods for augmenting kidney function

#9223
20110097306
2011-04-28

Oral formulations of cladribine

#9224
20110097304
2011-04-28

COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION

#9225
20110097303
2011-04-28

Methods and compositions for treating and preventing viral infections

#9226
20110097286
2011-04-28

COMPOSITIONS AND METHODS FOR INHIBITING PAR2 ACTIVATION OF KERATINOCYTES

#9227
20110097282
2011-04-28

Use for budesonide and formoterol

#9228
20110093020
2011-04-21

Polyporous hollow bone screw

#9229
20110092594
2011-04-21

USE OF NITRATED LIPIDS FOR TREATMENT OF LIPID DISORDERS AND OBESITY, AND LIPID- AND OBESITY-RELATED CONDITIONS

#9230
20110092589
2011-04-21

Treatment of Inflammatory Conditions and Diseases with Metal-Thiols

#9231
20110092587
2011-04-21

Branched-chain amino acid composition for improving skeletal muscle protein metabolism

#9232
20110092585
2011-04-21

IMMUNOMODULATORY PHARMACEUTICAL COMPOSITION AND A PROCESS FOR PREPARATION THEREOF

#9233
20110092563
2011-04-21

STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY

#9234
20110092552
2011-04-21

Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids

#9235
20110092550
2011-04-21

Combinations of imazalil and hydroxypyridones

#9236
20110092541
2011-04-21

Compositions for preventing and/or treating degenerative disorders of the central nervous system

#9237
20110092532
2011-04-21

APOMORPHINE PHARMACEUTICAL DOSAGE SECURITY SYSTEM

#9238
20110092528
2011-04-21

Piperidinyl compounds that selectively bind integrins

#9239
20110092522
2011-04-21

Wound and skin care compositions

#9240
20110092510
2011-04-21

DPP-IV INHIBITORS FOR USE IN THE TREATMENT OF NAFLD

#9241
20110092500
2011-04-21

SGC STIMULATORS, SGC ACTIVATORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF HEARING IMPAIRMENT

#9242
20110092488
2011-04-21

Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections

#9243
20110092482
2011-04-21

Methods and compositions

#9244
20110092471
2011-04-21

Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

#9245
20110092464
2011-04-21

NEUROGENESIS BY MODULATING ANGIOTENSIN

#9246
20110092463
2011-04-21

COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS

#9247
20110092462
2011-04-21

USE OF HIGH-DOSE OXAZAPHOSPHORINE DRUGS FOR TREATING IMMUNE DISORDERS

#9248
20110092456
2011-04-21

Methods of increasing cAMP levels and uses thereof

#9249
20110092454
2011-04-21

Methods For Treating Mycoplasma Related Conditions In Livestock

#9250
20110092449
2011-04-21

TREATMENT OF FIBROTIC CONDITIONS

#9251
20110092447
2011-04-21

USING INHIBITORS OF HISTONE DEACETYLASES FOR THE SUPPRESSION THERAPY OF INHERITED DISEASE PREDISPOSING CONDITIONS

#9252
20110092440
2011-04-21

METHOD OF REGULATING CELL GROWTH USING A PROTEASOME INHIBITOR

#9253
20110092430
2011-04-21

METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE

#9254
20110092416
2011-04-21

Vitamine B12 - Peptide Conjugates for Oral Delivery

#9255
20110091995
2011-04-21

DIVA (differentiate infected from vaccinated animals)

#9256
20110091605
2011-04-21

Process for extracting bioactive calcium ion

#9257
20110091586
2011-04-21

Compositions containing amines and use thereof

#9258
20110091585
2011-04-21

Herbal compositions and methods for enhancing vital energy and athletic performance

#9259
20110091583
2011-04-21

ANTIALLERGIC MARINE BIOPOLYMERS

#9260
20110091578
2011-04-21

Method of stimulating tissue healing

#9261
20110091574
2011-04-21

TREATMENT OF ADENOCARCINOMA EXPRESSING LKB1 WITH MTOR INHIBITOR IN COMBINATION WITH COX2 INHIBITOR

#9262
20110091573
2011-04-21

Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

#9263
20110091572
2011-04-21

ACNE TREATMENT COMPOSITIONS COMPRISING NANOSILVER AND USES

#9264
20110091570
2011-04-21

Compositions and Devices for Antisepsis and Anticoagulation

#9265
20110091560
2011-04-21

COMPOSITIONS OF NANOPARTICLES AND METHODS OF MAKING THE SAME

#9266
20110091559
2011-04-21

COMPOSITIONS COMPRISING ADJUVANT, MACROLIDE AND PROTEINACEOUS ANTIGEN AND METHODS OF USE THEREOF

#9267
20110091544
2011-04-21

Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting

#9268
20110091538
2011-04-21

POLYMER ADAPTED TO RELEASE BIOACTIVE AGENTS IN VIVO, PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION THEREOF

#9269
20110091530
2011-04-21

Oligopeptide tyrosinase inhibitors and uses thereof

#9270
20110091527
2011-04-21

Compositions and methods for reducing scar formation in wound healing

#9271
20110091486
2011-04-21

INHIBITION OF POST-RADIATION TUMOR GROWTH

#9272
20110091484
2011-04-21

Compositions and methods for preventing or treating a viral infection

#9273
20110091473
2011-04-21

NOVEL ANTIBODY THERAPIES

#9274
20110091472
2011-04-21

COMPOSITIONS FOR TREATING PSORIASIS

#9275
20110091470
2011-04-21

ANTI-FLT3 ANTIBODIES

#9276
20110091459
2011-04-21

IMIDAZOLE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M3

#9277
20110091453
2011-04-21

METHODS OF ADMINISTERING/DOSING CD2 ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISORDERS OR INFLAMMATORY DISEASES

#9278
20110091447
2011-04-21

LYMPHOCYTE CONTROL OF OBESITY AND INSULIN RESISTANCE

#9279
20110091440
2011-04-21

Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases

#9280
20110091436
2011-04-21

Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments

#9281
20110091435
2011-04-21

PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF HAIR LOSS

#9282
20110091431
2011-04-21

COMPOSITIONS AND METHODS COMPRISING PEDIOCOCCUS FOR REDUCING AT LEAST ONE SYMPTOM ASSOCIATED WITH AUTISM SPECTRUM DISEASE IN A PERSON DIAGNOSED WITH AN AUTISM SPECTRUM DISEASE

#9283
20110091427
2011-04-21

METHODS FOR TREATING A KIDNEY INJURY

#9284
20110091425
2011-04-21

Upregulation of opioid receptors for management

#9285
20110091423
2011-04-21

Compositions and methods of use of ritonavir for treating HCV

#9286
20110091418
2011-04-21

METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS

#9287
20110091415
2011-04-21

Hydroxyethyl Starch-Containing Polypeptide Compositions

#9288
20110091392
2011-04-21

Compositions for the treatment and prevention of infections of the oral cavity

#9289
20110091375
2011-04-21

USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA

#9290
20110086923
2011-04-14

Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons

#9291
20110086917
2011-04-14

Use of L-carnitine for the treatment of cardiovascular diseases

#9292
20110086914
2011-04-14

Methods for Treating Traumatic Brain Injury

#9293
20110086907
2011-04-14

ACNE TREATMENT

#9294
20110086892
2011-04-14

Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions

#9295
20110086874
2011-04-14

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

#9296
20110086873
2011-04-14

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

#9297
20110086870
2011-04-14

Combination Therapy

#9298
20110086847
2011-04-14

THIADIAZOLE MODULATORS OF BETA ADRENERGIC RECEPTOR

#9299
20110086845
2011-04-14

Compositions and methods for treating neurodegenerating diseases

#9300
20110086826
2011-04-14

LIPOSOMAL CAMPTOTHECINS AND USES THEREOF